|
|
Prepublished online as a Blood First Edition Paper on June 28, 2002; DOI 10.1182/blood-2002-01-0281.
Previous Article | Table of Contents | Next Article 
Blood, 1 August 2002, Vol. 100, No. 3, pp. 1072-1074
BRIEF REPORT
A 2-kb c-mpl promoter fragment is sufficient to direct
expression to the megakaryocytic lineage and sites of embryonic
hematopoiesis in transgenic mice
Sandra Ziegler,
Kurt Bürki, and
Radek C. Skoda
From the Biozentrum, University of Basel, DKF2,
Heidelberg, Germany, and Institute for Laboratory Animal Sciences,
University of Zurich, Switzerland.
Thrombopoietin receptor c-mpl is expressed on
hematopoietic progenitors and cells of the megakaryocytic lineage. The
c-mpl promoter may, therefore, be useful for directing the
expression of transgenes. We tested whether a 2-kb genomic DNA fragment
comprising the putative c-mpl regulatory elements and most
of the 5'-untranslated region of mouse c-mpl is able to
direct the expression of a reporter gene to hematopoietic cells in
transgenic mice. As a reporter gene we used the human placental
alkaline phosphatase (PLAP). In adult transgenic mice, PLAP expression
was specifically detected in megakaryocytes and platelets. Embryos
showed PLAP reporter gene expression already in the yolk sac at
embryonic day 6.5 (E6.5) and in blood islands at E7.5. At E9.5,
expression was found in blood vessels of the yolk sac and the embryo
proper, followed by high levels of expression in the fetal liver at
E11.5. Expression in E6.5 yolk sac is compatible with a function of
c-mpl and its ligand, thrombopoietin, in the earliest
stages of embryonic hematopoiesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. N. Constantinescu
Mpl and thrombocytosis: levels matter
Blood,
February 19, 2009;
113(8):
1617 - 1618.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Lannutti, A. Epp, J. Roy, J. Chen, and N. C. Josephson
Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis
Blood,
February 19, 2009;
113(8):
1778 - 1785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tiedt, J. Coers, S. Ziegler, A. Wiestner, H. Hao-Shen, C. Bornmann, J. Schenkel, S. Karakhanova, F. J. de Sauvage, C. W. Jackson, et al.
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes
Blood,
February 19, 2009;
113(8):
1768 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Petit-Cocault, C. Volle-Challier, M. Fleury, B. Peault, and M. Souyri
Dual role of Mpl receptor during the establishment of definitive hematopoiesis
Development,
August 15, 2007;
134(16):
3031 - 3040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gottgens, C. Broccardo, M.-J. Sanchez, S. Deveaux, G. Murphy, J. R. Gothert, E. Kotsopoulou, S. Kinston, L. Delaney, S. Piltz, et al.
The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5' Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1
Mol. Cell. Biol.,
March 1, 2004;
24(5):
1870 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|